Current Drug Safety
Volume 14, 3 Issues, 2019
ISSN: 2212-3911 (Online)
ISSN: 1574-8863 (Print)
This journal supports open access
ISSN: 2212-3911 (Online)
ISSN: 1574-8863 (Print)
This journal supports open access
Contents
Current Drug Safety, Volume 5 - Number 1
Medication Error Analysis: A Systematic Approach
, 5(1): 2 - 5Gourang P. Patel and Sandra L. Kane-Gill
DOI: 10.2174/157488610789869274
Optimizing Sustained Use of Sedation in Mechanically Ventilated Patients: Focus on Safety
, 5(1): 6 - 12Heather M. Arnold, James M. Hollands, Lee P. Skrupky and Scott T. Micek
DOI: 10.2174/157488610789869102
Technology Utilization to Prevent Medication Errors
, 5(1): 13 - 18Allison Forni, Hanh T. Chu and John Fanikos
DOI: 10.2174/157488610789869193
Safe Utilization of Hyperglycemia Management in the ICU
, 5(1): 19 - 21Mira Loh-Trivedi and W. Christopher Croley
DOI: 10.2174/157488610789869175
Approaches for Administering Chemotherapy in the Intensive Care Unit
, 5(1): 22 - 32Nicole Pitello, Michelle Treon, Kellie L. Jones and Patrick J. Kiel
DOI: 10.2174/157488610789869238
Systemic Approach to Parenteral Nutrition in the ICU
, 5(1): 33 - 40Sarah Peterson and Yimin Chen
DOI: 10.2174/157488610789869139
Mechanisms of Drug Induced QT Interval Prolongation
, 5(1): 44 - 53Marcelo Luis Ponte, Guillermo Alberto Keller and Guillermo Di Girolamo
DOI: 10.2174/157488610789869247
QT Interval Prolongation: Preclinical and Clinical Testing Arrhythmogenesis in Drugs and Regulatory Implications
, 5(1): 54 - 57Mariano A. Giorgi, Ricardo Bolanos, Claudio Daniel Gonzalez and Guillermo Di Girolamo
DOI: 10.2174/157488610789869148
Antihistamines: Past Answers and Present Questions
, 5(1): 58 - 64Guillermo Alberto Keller and Guillermo Di Girolamo
DOI: 10.2174/157488610789869201
Cardiovascular Drugs Inducing QT Prolongation: Facts and Evidence
, 5(1): 65 - 72Carlos A. Taira, Javier A.W. Opezzo, Marcos A. Mayer and Christian Hocht
DOI: 10.2174/157488610789869229
Prokinetic Agents and QT Prolongation: A Familiar Scene with New Actors
, 5(1): 73 - 78Guillermo Alberto Keller and Guillermo Di Girolamo
DOI: 10.2174/157488610789869166
Endocrine Therapies and QTc Prolongation
, 5(1): 79 - 84Claudio Daniel Gonzalez, Martha de Sereday, Isaac Sinay and Silvina Santoro
DOI: 10.2174/157488610789869157
Antimicrobial Agents-Associated with QT Interval Prolongation
, 5(1): 85 - 92Fernando Bril, Claudio Daniel Gonzalez and Guillermo Di Girolamo
DOI: 10.2174/157488610789869184
Antineoplastic Chemotherapy Induced QTc Prolongation
, 5(1): 93 - 96Claudia Bagnes, Patricia Natalia Panchuk and Gonzalo Recondo
DOI: 10.2174/157488610789869111
QT Alterations in Psychopharmacology: Proven Candidates and Suspects
, 5(1): 97 - 104Paulino Antonio Alvarez and Jaime Pahissa
DOI: 10.2174/157488610789869265
Other Drugs Acting on Nervous System Associated with QT-Interval Prolongation
, 5(1): 105 - 111Guillermo Alberto Keller, Marcelo L. Ponte and Guillermo Di Girolamo
DOI: 10.2174/157488610789869256
  |
Editor-in-Chief
Dr. Seetal Dodd
University of Melbourne
Geelong, Melbourne
Australia
Biography
View Full Editorial Board
University of Melbourne
Geelong, Melbourne
Australia
Biography
Biography of Seetal Dodd
Dodd obtained a doctorate (Ph.D.) from the University of Melbourne, Australia. He is a Principal Fellow in the Department of Psychiatry, University of Melbourne, a Clinical Associate Professor at the Centre for Youth Mental Health, University of Melbourne, and a Clinical Associate Professor in the School of Medicine, Deakin University, Australia. He has published over 180 scientific publications. A/Prof Dodd is currently Editor-in-Chief of Current Drug Safety, published by Bentham Science Publishers.
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Drug Safety Journal was launched in 2006. Dr. Seetal Dodd serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net